We use cell, molecular and biochemical approaches, experimental models, human data and bioinformatic analysis to dissect the interface between aging and cancer, and identify novel therapeutics to attenuate aging/diabetes, muscle degeneration, metastatic triple-negative breast cancer and pineoblastoma.